Brokers Set Expectations for Tempest Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:TPST) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
In an unprecedented leap in oncology therapeutics, Tempest Therapeutics presents compelling data at ASCO 2024, underscoring its commitment to revolutionize liver cancer treatment. The company s novel.
Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
TPST-1120 demonstrates superiority compared to standard of care across multiple study endpoints in randomized first-line HCC studyNew capital strengthens balance sheet and extends cash runway into.